Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-017892
Filing Date
2014-03-06
Accepted
2014-03-06 16:39:00
Documents
2
Period of Report
2014-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1511
2 EX-24 DOCUMENT attachment1.htm EX-24 3646
  Complete submission text file 0001209191-14-017892.txt   6492
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERMUNE, INC. 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address
Russell Angus C. (Reporting) CIK: 0001534002 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 14673491